SEC Form 4 · accession 0001179110-17-009461
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Santiago Arroyo
Officer — SVP, Chief Medical Officer
Period of report
Jun 20, 2017
Accepted (ET)
Jun 22, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2017 | A | 36,000 | $0.00 | A | 36,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F3 | $17.20 | Jun 20, 2017 | A | 150,000 | A | — | Jun 20, 2027 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Represents 36,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Incentive Award Plan, as amended and restated, and subject to a restricted stock agreement to be entered into between the Company and Dr. Arroyo. Pursuant to the restricted stock agreement, the shares of restricted common stock shall vest on the achievement of certain company goals within a specified time period.
- F2Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan.
- F3The stock option will vest and become exercisable with respect to 37,500 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. All vesting is subject to Dr. Arroyo's continued service to the Company through the applicable vesting date.